Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Aging muscles aren't just failing — they're adapting. Scientists have uncovered two distinct mechanisms behind age-related muscle weakness: a drop in a key mitochondrial molecule called cardiolipin, and a breakdown in nerve-to-muscle communication. In mice, partially restoring cardiolipin reversed muscle wasting, while blocking a protein called ClC-1 improved muscle responsiveness — opening new doors for treating sarcopenia.
Aging muscles aren't simply deteriorating — they're making a trade-off. Two new studies shed light on why older adults lose strength, revealing mechanisms that go far deeper than muscle mass alone.
One team from the University of Copenhagen found that cardiolipin — a fat molecule critical to mitochondrial function — declines in aging muscle cells. This triggers a shift from powerful fast-twitch fibers to endurance-oriented slow-twitch fibers, which turns out to be a protective response: muscles reroute glucose to produce antioxidants and shield cells from damage caused by dysfunctional mitochondria. Remarkably, partially restoring cardiolipin levels in mice reversed muscle wasting and prevented premature death.
A separate team, publishing in the Journal of Clinical Investigation, identified another culprit: a breakdown at the neuromuscular junction — the point where nerves tell muscles to contract. Depleted levels of a sodium channel protein (NaV1.4) mean muscles can't "hear" nerve signals clearly. Blocking a protein called ClC-1 bypassed this failure and restored muscle function in aged rodents, with a candidate drug (ignaseclant) already in human trials for other conditions.
Key Takeaways
Why it matters: Sarcopenia affects nearly half of adults over 80 and has no approved drug treatment. These findings offer two distinct, potentially druggable pathways — and challenge the assumption that muscle loss is simply inevitable with age.
